JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation.
Biomed Pharmacother
; 144: 112281, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-34624676
ABSTRACT
Schistosomiasis is a serious parasitic infection caused by Schistosoma. The parasite deposits eggs in the host liver, causing inflammation that activates hepatic stellate cells (HSCs), which leads to liver fibrosis. Currently, there is no effective therapy for liver fibrosis; thus, treatments are urgently needed. Therefore, in the present study, mice infected with Schistosoma japonicum were treated with JQ-1, a small-molecule bromodomain inhibitor with reliable anti-tumor and anti-inflammatory activities. The fibrotic area of the liver measured by computer-assisted morphometric analysis and the expression levels of the cytoskeletal protein alpha smooth muscle actin (α-SMA) and of collagen assessed by quantitative PCR, Western blot and immunohistochemistry were significantly decreased in the liver following JQ-1 treatment compared with vehicle-treated controls. Total RNA was extracted from the liver of JQ-1-treated Schistosoma-infected mice for RNA-sequencing analysis. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses indicated that JQ-1 affected biological processes and the expression of cellular components known to play key roles in the transdifferentiation of HSCs to myofibroblasts. In vitro treatment with JQ-1 of JS-1 cells, a mouse HSC line, indicated that JQ-1 significantly inhibited JS-1 proliferation but had no effect on JS-1 activity, senescence, or apoptosis. Western blot results showed that JQ-1 inhibited the expression levels of phosphorylated JAK2 and phosphorylated STAT3 without altering expression levels of these non-phosphorylated proteins. Taken together, these findings suggested that JQ-1 treatment ameliorated S. japonicum egg-induced liver fibrosis, at least in part, by suppressing HSC activation and proliferation through the inhibition of JAK2/STAT3 signaling. These results lay a foundation for the development of novel approaches to treat and control liver fibrosis caused by S. japonicum.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Schistosoma japonicum
/
Esquistosomiasis
/
Azepinas
/
Triazoles
/
Factor de Transcripción STAT3
/
Janus Quinasa 2
/
Células Estrelladas Hepáticas
/
Antifibróticos
/
Hígado
/
Cirrosis Hepática
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Biomed Pharmacother
Año:
2021
Tipo del documento:
Article